<?xml version="1.0" encoding="UTF-8"?>
<p>Lopinavir/ritonavir (a potent CYP3A4-inhibiting drug) is used to treat human immunodeficiency virus (HIV) infection and is now under investigation for use in COVID-19 patients. Lopinavir/ritonavir may cause PR and QT-interval prolongation especially in patients taking other QT-prolonging drugs or those with prolonged QT at baseline.
 <sup>
  <xref rid="bibr11" ref-type="bibr">11</xref>
 </sup>
</p>
